Treatment Discontinuation of Blood Pressure–Lowering Drugs
To the Editor Dr Wang and colleagues recently published a comprehensive network meta-analysis of adverse effects and treatment discontinuation of blood pressure–lowering drugs, synthesizing 716 trials with 159 362 participants. However, the choice of a fixed-effects model for the primary analysis warrants discussion.